ClearPoint Neuro raises at-the-market equity offering limit to $150 million
CLPT•ClearPoint Neuro increased its at-the-market common stock offering capacity to $150 million from $50 million on November 18, 2026. About $22.5 million has already been sold, while shares available under the existing prospectus supplement remain approximately $27.5 million.




